' INTRODUCTION
The chlorinated diphenylurea antimicrobial compound triclocarban (3, 4, 4 0 -trichlorocarbanilide, TCC) is widely used as an active ingredient in personal care products, mostly added to consumer deodorant soaps. TCC is active predominantly against Gram-positive bacteria. 1 A study reported that around 30% of bar soaps on the market contain this antimicrobial. 2 Exposure to TCC occurs through the use of personal care products containing TCC, with the main route of exposure likely to be dermal. In the environment, TCC has been detected at microgram per liter levels in surface water, suggesting wide-ranging contamination of aquatic ecosystems in the United States. 3, 4 TCC partitions to sewage sludge and survives anaerobic digestion. 5 Biosolids from wastewater treatment are often applied to land as fertilizer, providing another potential route of entry to the aquatic environment and possibility for accumulation in soil.
The potential of this compound for bioaccumulation and exposure has raised public concern regarding its possible effects on human health due to unintended biological/physiological effects, toxicity, and microbial resistance. 6À11 Indeed, the state of California has listed triclocarban as a designated chemical in their Environmental Contaminant Biomonitoring Program. 12 Studies have reported that TCC enhances the activity of steroid hormones such as androgens and estrogens in in vitro biological tests. 13, 14 TCC enhanced the production of embryos in the freshwater mudsnail. 15 TCC and its urea analogues strongly inhibited the activity of soluble epoxide hydrolase, which plays an important role in metabolism of fatty acid epoxides to their corresponding 1,2-diols, leading to the accumulation of epoxyeicosatrienoic acids and other epoxides in the organism. 16, 17 In light of these biologies and that TCC is clearly absorbed during showering, 18, 19 further investigations into the biological and toxicological effects of TCC are warranted. A routine assay for screening or monitoring TCC would be a useful research tool, as epidemiological screens for this compound are of increasing interest.
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of choice when a research project investigates a delicate and varying series of actions on limited samples. However, for a large number of samples, where a single analyte is of interest, an inexpensive, simple, rapid, and high-throughput method is needed. Immunoassay methods were described as a rapid screening method for environmental contaminants, pesticides, and their degradation products in environmental chemistry. 23 These techniques are widely used in clinical diagnostics, environmental monitoring, food quality, agriculture, and field or on-site testing of personnel exposed to toxic chemicals and are particularly useful for laboratories that do not have LC-MS/MS capability as well as other resource limited settings. The objective of this study is the development of an enzyme-linked immunosorbent assay (ELISA) for the analysis of TCC that uses a polyclonal antibody as a simple monitoring tool.
' EXPERIMENTAL SECTION Chemicals and Instruments. The hapten coupling reagents, bovine serum albumin (BSA), conalbumin (CON), thyroglobulin (Thy), goat anti-rabbit IgG peroxidase conjugate (GAR-HRP), Tween 20, 3, 3 0 ,5,5 0 -tetramethylbenzidine (TMB), and carbanilide were purchased from SigmaÀAldrich Chemical Co. (St. Louis, MO). Triclocarban (SigmaÀAldrich) was recrystallized three times from hot methanol to yield >99.9% pure material as measured by HPLC. 13 3-Trifluoromethyl-4,4 0 -dichlorocarbanilide (TFC) was from Chembridge (San Diego, CA), while triclosan was from Fluka (St. Louis, MO). 2 0 -Hydroxytriclocarban (2 0 -OH TCC), its sulfate conjugate, diuron, 4,4 0 -dichlorocarbanilide, and soluble epoxide hydrolase (sEH) inhibitors 1555 and 1709 were synthesized by condensing the appropriate isocyanate and amine according to previously published methods. 24, 25 ELISA was performed on 96-well microtiter plates (Nunc MaxiSorp, Roskilde, Denmark) and read spectrophotometrically with a microplate reader (Molecular Devices, Sunnyvale, CA) in dualwavelength mode (450À650 nm). LC-MS/MS analysis was conducted by electrospray ionization in negative mode using a Quattro Ultima tandem quadrupole mass spectrometer (Waters, Milford, MA) in multiple reaction monitoring mode interfaced with a Shimadzu LC-10A separation module (Shimadzu, Columbia, MD) utilizing a C8 Zorbax column. Details of the separation and detection conditions are described in the Supporting Information.
Hapten Synthesis. Because TCC is of small molecular weight, it requires conjugation to carrier proteins in order to be immunogenic. TCC haptens containing a reactive carboxylic acid or a primary amine group were designed and synthesized in this laboratory. Five classes of hapten were utilized ( Figure 1 ). The main reactions to prepare haptens containing a chlorinated diphenyl urea moiety were based on methods previously described involving condensation of an isocyanate and an amine. 24, 26 The synthesis of haptens is detailed in the Supporting Information.
Preparation of Immunogen and Coating Antigens. For haptens with a reactive carboxylic acid group, conjugation to proteins was made by the N-hydroxysuccinimide (NHS) or sulfo-NHS-carbodiimide method, and for haptens with an amine group, by the diazotization method, 27 respectively. Type A, B, and C haptens ( Figure 1 ) were conjugated to Thy for immunogen preparation. Type AÀE haptens were conjugated to BSA or CON to prepare coating antigens.
Sulfo-N-hydroxysuccinimide Method. Haptens type A, B, and C were coupled covalently with the lysine moieties of carrier proteins. That is, each hapten (0.02 mmol) was dissolved in 1 mL of dimethylformamide (DMF) with sulfo-NHS (0.024 mmol) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 0.024 mmol). After the mixture was stirred overnight, the active ester was added slowly to a solution of Thy (25 mg of protein in 1 mL of 0.05 M borate buffer at pH 8) with vigorous stirring. The reaction mixture was stirred gently at 4°C for 24 h to complete the conjugation. The conjugates were dialyzed (Spectra/ Por, molecular weight cutoff 6000À8000, Spectrum Laboratories, Rancho Dominguez, CA) against phosphate-buffered saline (PBS) for 36 h with buffer changes every 12 h and stored at À20°C until use. Environmental Science & Technology ARTICLE Diazotization Method. Hapten type D was covalently conjugated to the carrier protein. That is, 0.2 N sodium nitrite (0.5 mL) was added dropwise to a solution of hapten D1 (0.03 mmol) dissolved in a mixture of a few drops of ethanol and 0.2 N HCl (0.5 mL) until a positive starch iodide test was confirmed. The reaction vial was cooled with ice while the solution was stirred. DMF (0.3 mL) was added, and the solution was stirred for 10 min and then divided into two equal aliquots. One aliquot was added to a solution of BSA, and the other to a solution of CON. BSA (25 mg) and CON (25 mg) were dissolved in 5 mL of ice-cold borate buffer (0.2 M, pH 8.9). The reaction mixtures were cooled in an ice bath and stirred continuously for 30 min. The pH of the yellow solutions was then adjusted to 7.0 with 1 N NaOH. Each mixture was dialyzed and stored as described above.
N-Hydroxysuccinimide Active Ester Method. Type E haptens were coupled covalently to BSA and CON by the activated ester method. That is, each hapten (0.04 mmol) was dissolved in 0.2 mL of dry DMF with equimolar NHS and a 10% molar excess of dicyclohexylcarbodiimide. After the mixture was stirred overnight at 22°C, the precipitated dicyclohexylurea was removed by filtration through a glass wool-plugged Pasteur pipet, and about 0.2 mL of the active ester was added slowly to a solution of the protein (25 mg of protein in 1 mL of 0.05 M borate buffer at pH 8) with vigorous stirring. The reaction mixture was stirred gently at 4°C for 24 h to complete the conjugation and then dialyzed and stored as described above.
Immunization and Antiserum Preparation. The immunization procedure followed the protocol reported previously. 28 Three female New Zealand white rabbits were immunized for each immunogen (rabbits 1639/1640/1641, hapten A1-Thy; rabbits 1642/1643/1644, hapten A2-Thy; rabbits 1645/1646/1647, hapten B1-Thy; and rabbits 1648/1649/1650, hapten C1-Thy). The final bleed was collected about 5 months following the first immunization. Blood was collected in test tubes and allowed to clot. Serum was obtained by centrifugation, stored at À20°C, and used without purification.
Competitive Indirect ELISA. Preparation of buffers and the procedure for indirect competitive ELISA were previously described. 29 The library of coating antigens was screened against the various rabbit antisera. The assay having the lowest IC 50 with a maximum absorbance of at least 1.0 was chosen for further studies. The IC 50 value, an expression of the sensitivity of immunoassay and the limit of detection (LOD), defined as the IC 10 value, were obtained from a four-parameter logistic equation. Borosilicate glass tubes were used to prepare standard and sample solutions to minimize the surface adsorption of TCC. Each standard was analyzed in four well replicates on the same plate, and each plate contained a complete standard curve.
Cross-Reactivity. The cross-reactivity (CR) studies were evaluated by using standard solutions of synthesized TCC metabolites and urea analogues. 13 The compounds tested are listed in Table 1 . Each concentration of each compound was tested in four well replicates. The CR was calculated as (IC 50 of target analyte/IC 50 of tested compound) Â 100.
Immunological Analysis of Biological and Environmental Samples. Human Whole Blood and Sera of Calf and Mice. Methods for serum and blood sample analysis were optimized for two sample sizes (0.5 mL and 10 μL). Commercial calf (Invitrogen, Carlsbad, CA) or human serum (Sigma S-7023, St. Louis, MO) was kept at À20°C until the analysis. After thawing, 0.5 mL of the serum was transferred to a 5 mL glass test tube. TCC (500 μg/L) dissolved in methanol was used to prepare three replicates each of samples containing 3, 5, 10, and 50 ng of TCC/mL of serum for a recovery study. Each sample was diluted with 2 mL of sodium acetate buffer (0.2 M, pH 4.5). TCC was extracted with ethyl acetate (2 mL Â 2). Centrifugation was utilized when needed. The combined organic layers were completely removed by a centrifugal vacuum evaporation overnight. The residue was redissolved with dimethyl sulfoxide (DMSO; 0.5 mL), followed by the addition of phosphatebuffered saline (PBS; 2 mL) to make a 5-fold dilution prior to analysis. Each sample was analyzed in three well replicates.
For the 10 μL sample, commercial human serum and whole blood (Innovative Research Inc., Novi, MI) were kept at À20 and 4°C prior to use, respectively. After being thawed, 0.5 mL of the serum was transferred to a 1 mL centrifuge tube to prepare spiked samples. TCC (500 ng/mL) dissolved in methanol was used to prepare three replicates each of concentrations of 5, 10, 25, 50, and 100 ng of TCC/mL of serum. Aliquots (10 μL) of each sample were added into a 1-mL microcentrifuge tube containing 50 μL of distilled water. The pipet tip was washed once with water that was added to the tube. The tube was shaken, 200 μL of ethyl acetate was added, and the tube was capped. The mixture was vigorously shaken for about 60 s on a Vortex mixer and then centrifuged at 8160g at room temperature for 5 min (Eppendorf, Hamburg, Germany). The ethyl acetate layer was removed and the aqueous layer was again extracted with 200 μL of ethyl acetate. The combined ethyl acetate layers were evaporated to dryness by a vacuum centrifugal concentrator and dissolved in 28 μL of DMSO, followed by addition of 42 μL of PBS prior to the immunoassay. Final dilution was 7-fold in the assay buffer prior to analysis. Each sample was analyzed in three well replicates.
The same extraction method was used for blood samples collected from volunteers who used a retail solid soap containing TCC. Whole blood (10 μL) was carefully collected in a pipet tip prerinsed with tripotassium ethylenediaminetetraacetate (K 3 -EDTA) by use of a 20-μL pipet. Samples were extracted as above and the dried extracts were dissolved in 24 μL of DMSO, followed by addition of 36 μL of PBS prior to the immunoassay. Final dilution was 6-fold in the assay buffer. Each sample was analyzed in triplicate.
Whole blood samples (10 μL) were collected from mice fed a rat chow containing 0.2% TCC (w/w). The sample was added into a 1 mL microcentrifuge tube including 50 μL of distilled water. The extraction method was the same as described above. Each sample was analyzed in triplicate. Final dilution was 6-fold in the assay buffer.
Human Urine. Frozen urine samples collected from volunteers exposed to TCC were thawed at room temperature. The thawed sample was shaken vertically for 30 s to completely mix the sample. The sample was allowed to stand for at least 2 h at room temperature. A 0.5 mL aliquot of the clear supernatant was added to a glass screw-capped vial (15 mm Â 4.5 mm, 1 dram, 4 mL). To hydrolyze possible TCC conjugates in urine to free TCC, in the fume hood, a 0.1 mL aliquot of 6 N HCl was added and the tube was capped. The capped tube was placed in a Dri-bath heating block set at 100°C for 20 min in the fume hood. After cooling, the acid mixture was neutralized with about 0.08 mL of 6 N NaOH. Acetic acid in water (1%, 1.5 mL) was added to the tube and mixed thoroughly. A 0.2-mL aliquot of the sample was extracted three times with 0.5 mL of ethyl acetate by shaking vigorously for 5 min at 220 rpm on an orbital shaker or for 1 min on a vortex mixer. After the sample had been centrifuged, the organic layers were combined in a 12 mm Â 75 mm glass tube.
The extract was evaporated to dryness under a gentle stream of N 2 gas. The residue was dissolved in 100 μL of DMSO, followed by the addition of 150 μL of PBS for ELISA analysis. Three replicates of each sample were extracted and analyzed in triplicate. For the recovery study, 500 ng/mL TCC dissolved in methanol was spiked into 0.5 mL of urine in the range 10À 100 ng/mL before hydrolysis. Three replicates were prepared at each concentration, and each sample was analyzed in triplicate.
Analysis of Biosolid Samples. Three biosolid samples were collected from the outflow of a sludge holding pond at a wastewater treatment plant that has a capacity of about 140 million gallons per day. The samples were dried at 70°C for 24 h and homogenized with a mortar and pestle. A mixture of methanol and acetone (1:1 v/v, 15 mL) was added to 1 g of dried sample. The mixture was shaken for 24 h at 210 rpm at 60°C and centrifuged for 30 min at 10000g. The supernatant was filtered with a 0.2 μm poly(tetrafluoroethylene) (PTFE) filter. Each sample was processed in triplicate. The extracts were further diluted in methanol/acetone for LC-MS/MS analysis or 50À200-fold in 40% DMSO/PBS prior to the immunoassay.
' RESULTS AND DISCUSSION Synthesis of Haptens. The design and synthesis of immunizing haptens is critical to the development of immunoassays for small molecules in order to produce sensitive and specific antibodies to the target. 30 TCC is of small molecular weight (MW 316) and requires conjugation to carrier proteins in order to be immunogenic. Antibodies are generally formed to the part of the molecule that is most distal to the point of attachment to the carrier protein. Haptens with a functional group (-COOH or -NH 2 ) for conjugation to carrier proteins were designed (Figure 1 ). Mainly haptens were synthesized by a reaction that condensed the appropriate isocyanate and an amine (Supporting Information Schemes S1ÀS7).
The main idea for immunizing hapten design was to prepare a hapten that simulated the entire TCC molecule and contained a carbon linker and a carboxylic group. The numbers of carbon in the linker were 0, 3, or 4, and the linkers were attached at the 4 or 4 0 position of the structure. The immunizing haptens were divided into three different groups that exposed different parts of the TCC molecule for antibody recognition. All of the saturated hydrocarbon linkers of haptens of type A were introduced at the 4 0 -carbon position. Since S is an isosteric analogue of Cl, haptens of type B contained linkers in which S was introduced in place of Cl at the 4 0 -position, followed by the addition of a single hydrocarbon linker. For haptens of type C, S was also introduced in place of Cl at the 4-position in the same way as those in type B.
For polyclonal antibody-based immunoassays for smallmolecular-weight organic molecules, the relative binding affinity of the target analyte TCC to the antibody is increased by utilizing relatively low-affinity haptens (heterologous haptens) in the competitive assay format. An advantage of this approach is that the polyclonal antibody does not require purification from the serum because generally a dilution of 3À4 orders of magnitude is used. Because the development of heterologous immunoassays for small molecular weight targets requires synthesis of haptens, this technology is very attractive in laboratories with capability in organic synthesis.
Heterology in competitive haptens was achieved by altering the handle length (type A), altering substitutions in the handle Table S1 , Supporting Information).
Optimization. All of the immunizing haptens in types A, B, and C provided reasonable affinity of the resulting antibody to the target in a competitive assay format. Rabbit antisera 1648 and 1650, generated against immunizing hapten C1, provided the best sensitivity against selected competitive haptens conjugated to BSA and CON (Supporting Information Table S1 ). Among the most sensitive heterologous combinations of coating antigen and antibody, a pair consisting of hapten E2ÀBSA and antibody 1648 was selected for TCC analysis because of the sensitivity, reasonable signal-to-noise ratio, heterologous approach, and novelty of coating hapten structure. The optimum concentrations of hapten E2ÀBSA and antibody 1648 were 1 μg/mL to be coated onto the plate and 1:6000 dilution, respectively.
Since TCC is highly lipophilic and may be insoluble in the assay buffer, a high amount of cosolvent is very important for consistent assay performance and sensitivity. Varying concentrations of methanol and DMSO were evaluated, and generally DMSO increased the sensitivity more than methanol. DMSO (40% in the assay buffer) exhibited the highest sensitivity and an A/D ratio of 10 (Supporting Information Table S2 ), and this condition was selected for further experiments.
There was no significant effect of pH values ranging from 5.5 to 11 in the buffer on the IC 50 value, but the maximum absorbance values were less variable than effects of other parameters such as ionic strength and solvents (Supporting Information  Table S2 ). The pH of PBS was maintained at 7.5 for the assay.
Although the IC 50 value was not significantly affected by higher ionic strength, the absorbance reduction at 2Â PBS (0.3 M), 4Â PBS (0.6 M), or 6Â PBS (0.9 M) shows that the binding interaction of antibody to antigen was gradually suppressed (Supporting Information Table S2 ). Complete screening data are shown in Tables S1 and S2 in Supporting Information.
The optimized ELISA used coating antigen hapten E2ÀBSA at a concentration of 1 μg/mL and polyclonal antibody 1648 produced against hapten C1ÀThy at a dilution of 1/6000 prior to addition to the microtiter plate. The coated plate was blocked with 0.5% BSA. The assay buffer was 40% DMSO in 0.15 M PBS, pH 7.5. This heterologous assay had a linear range (IC 20À80 ) of 0.13À3.6 ng/mL of target analyte in the buffer system and an IC 50 value of 0.69 ng/mL. The LOD in the buffer was set as 0.03 ng/mL, the IC 10 value (Figure 2) .
Cross-Reactivity. TCC metabolites and analogues were evaluated for cross-reactivity (CR). The assay was selective for the target analyte TCC, showing low CRs (<10%) to other tested compounds (Table 1) . TFC (3-trifluoromethyl-4,4 0 -dichlorocarbanilide) has a -CF 3 group in place of Cl and showed relatively high CR (30%). TFC is also as an antimicrobial agent. 31 The antibody generated against the immunizing hapten likely has more affinity to the presence of both phenyl moieties rather than a single phenyl moiety, because diuron cross-reacted only 0.7%. The urea bridge of the TCC molecule is also a characteristic antigenic determinant because triclosan, a biphenyl ether, crossreacted <0.1%. Surprisingly, tetrachlorocarbanilide, which differs only in the addition of one symmetric chlorine, cross-reacted only 0.5%, possibly because the antibody binding pocket generated against haptens containing three chlorines was too small. However, the symmetrical dichlorocarbanilide cross-reacted significantly at 8.9% while the nonchlorinated carbanilide cross-reacted <0.1%, showing the importance of the chlorines. The low crossreactivity of two structural analogues that are inhibitors of the enzyme soluble epoxide hydrolase (sEH) further demonstrates the importance of the presence of chlorinated phenyl moieties.
Matrix Effects. Sample preparation is a critical step for accurate and reliable determination in many analytical methods. LiquidÀ liquid extraction (LLE) is an attractive alternative to solid-phase extraction (SPE) because of its relatively simple process, ease of development of the method, and removal of water-compatible salts. It results in a relatively clean extract having reduced matrix interference from blood and urine samples when analyzed by immunoassay or other instrumental methods. The LLE method described here used ethyl acetate as a simple method for crude screening of TCC in the blood/serum or urine, as demonstrated by the good recoveries seen for human whole blood. Upon extraction of serum, proteins formed a gel-like precipitate between organic and aqueous layers that was easily removed by centrifugation and caused no apparent matrix effect, as seen by the good overall recovery of TCC (Table 2) . Recoveries were in the range of 60À120% in serum/blood and urine samples. The results of TCC measured in samples prepared from the two sized samples (10 μL and 0.5 mL) were not appreciably different. Data are shown in Supporting Information Table S3 . The ability to utilize the 10 μL sample size is attractive, as samples can be obtained less invasively by finger prick, and validation in whole blood eliminates the need to obtain the serum.
Validation in Various Study Samples. For analysis of environmental biosolid samples, the ELISA was performed after a large dilution of the methanol/acetone extract in 40% DMSO/ PBS. Data from the ELISA analysis indicated slightly higher levels of TCC than data from LC-MS/MS analysis, with an average ratio of 1.4 (Table 3 ). This method may be useful for rapid analysis in a wastewater treatment plant to determine whether TCC was adequately removed during digestion processes.
As seen in Table 4 , there was relatively good agreement between ELISA and LC-MS/MS data for human whole blood collected from healthy volunteers, 2À3 h following a whole-body shower that included lathering 15 min with a commercial bar soap containing 0.6% TCC. Because of the good correlation, only the ELISA was used for the follow-up study. An individual performed their normal shower habits with the commercial bar soap, and whole blood samples were collected 2 h later. 19 Taken with the previous study, these results show that TCC is clearly absorbed and shower habit does not appear to make a difference in absorption. A similar correlation between methods was obtained for serum from mice treated with TCC. These assays were performed in a blind fashion (Table 4) .
TCC concentrations in urine collected over 5 days from a healthy volunteer that used a commercial TCC-containing bar soap when showering were much higher in acid-hydrolyzed samples than those in nonhydrolyzed ones (Supporting Information Table S4 ), suggesting that more conjugates are excreted by this route than parent compound. Thus, a hydrolysis step to release free TCC was used. TCC concentrations in hydrolyzed urine correlated well to those of LC-MS/MS (Figure 3 ). According to LC-MS/MS analysis, oxidative metabolites of TCC such as 2 0 -OH-TCC, 3 0 -OH-TCC, and 6-OH-TCC are minor in urine. The main metabolites of TCC were found to be N-and N 0 -glucuronic acids of TCC. 19, 32 For the urine samples, a background concentration of the analyte TCC was found in the predose samples and was subtracted from the amount measured in the samples collected after TCC exposure. A control matrix (unfortified sample matrix that is used for the fortified samples) was analyzed along with the fortified matrix to detect any background concentration of analyte present in the control. A background concentration of the analyte found in the control was subtracted from the amount measured in the fortified sample for comparison of results with LC-MS/MS. As shown in Figure 3 , TCC excretion reached a maximum at about 12 h and returned to pre-exposure levels by day 5. At 18 h, the TCC excretion appears to be low, but this is explained by a low creatinine level. Creatinine values are in Supporting Information Table S4 .
In conclusion, to develop a sensitive, selective immunoassay for TCC, the introduction of a saturated hydrocarbon spacer linked through a thioether, an isosteric analogue of Cl, as a good molecular mimic of TCC aided in the development of a selective a Sample sizes of human serum, whole blood, and urine were 10 μL, 10 μL, and 500 μL, respectively. Three samples were spiked at each concentration. Values are the mean ( standard deviation (n = 3) for the absolute recovery (ng/mL) and the relative recoveries (%). b Not determined. antibody, as previously demonstrated for triazine herbicides and other analytes.
33,34 A heterologous coating hapten having a piperidine moiety that influenced the affinity of the antibody for the analyte in the competitive assay resulted in a sensitive heterologous assay. This immunoassay format developed for TCC was highly sensitive, with IC 50 values of 0.70 ng/mL in a competitive indirect format. Ethyl acetate extraction of aqueous samples such as serum/blood and urine was used as a common sample preparation method prior to this immunoassay. This sample preparation method facilitated quantitative measurement in serum and urine and could be applied as well to environmental water samples. This technology was demonstrated to be applicable to as little as 10 μL of urine or serum. It also can be adapted for relatively highthroughput analysis. Finally, the techniques of immunizing and competitive hapten design, screening, and sample preparation can be applied to any immunoassay and should result in improved assays.
' ASSOCIATED CONTENT b S Supporting Information. Additional text, seven schemes, four tables, and one figure with details of hapten synthesis, antibody screening, optimization, recovery studies, and LC-MS/MS conditions. This material is available free of charge via the Internet at http://pubs.acs.org. 
